199 related articles for article (PubMed ID: 32159639)
1. Effects of hyperuricemia on incident renal replacement therapy and all-cause mortality among patients with chronic kidney disease stages 3-5: a retrospective cohort study.
Lee CL; Wang JS
Sao Paulo Med J; 2019; 137(6):523-529. PubMed ID: 32159639
[TBL] [Abstract][Full Text] [Related]
2. The role of uric acid in chronic kidney disease patients.
Hsieh YP; Chang CC; Yang Y; Wen YK; Chiu PF; Lin CC
Nephrology (Carlton); 2017 Jun; 22(6):441-448. PubMed ID: 26610276
[TBL] [Abstract][Full Text] [Related]
3. Association of hyperuricemia with renal outcomes, cardiovascular disease, and mortality.
Liu WC; Hung CC; Chen SC; Yeh SM; Lin MY; Chiu YW; Kuo MC; Chang JM; Hwang SJ; Chen HC
Clin J Am Soc Nephrol; 2012 Apr; 7(4):541-8. PubMed ID: 22300737
[TBL] [Abstract][Full Text] [Related]
4. Uric acid is not associated with decline in renal function or time to renal replacement therapy initiation in a referred cohort of patients with Stage III, IV and V chronic kidney disease.
Nacak H; van Diepen M; Qureshi AR; Carrero JJ; Stijnen T; Dekker FW; Evans M
Nephrol Dial Transplant; 2015 Dec; 30(12):2039-45. PubMed ID: 26185050
[TBL] [Abstract][Full Text] [Related]
5. Uric Acid and the Risks of Kidney Failure and Death in Individuals With CKD.
Srivastava A; Kaze AD; McMullan CJ; Isakova T; Waikar SS
Am J Kidney Dis; 2018 Mar; 71(3):362-370. PubMed ID: 29132945
[TBL] [Abstract][Full Text] [Related]
6. Uric acid and incident chronic kidney disease in a large health check-up population in Taiwan.
Wang S; Shu Z; Tao Q; Yu C; Zhan S; Li L
Nephrology (Carlton); 2011 Nov; 16(8):767-76. PubMed ID: 21854506
[TBL] [Abstract][Full Text] [Related]
7. Hyperuricemia and Progression of CKD in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort Study.
Rodenbach KE; Schneider MF; Furth SL; Moxey-Mims MM; Mitsnefes MM; Weaver DJ; Warady BA; Schwartz GJ
Am J Kidney Dis; 2015 Dec; 66(6):984-92. PubMed ID: 26209544
[TBL] [Abstract][Full Text] [Related]
8. J-shaped mortality relationship for uric acid in CKD.
Suliman ME; Johnson RJ; García-López E; Qureshi AR; Molinaei H; Carrero JJ; Heimbürger O; Bárány P; Axelsson J; Lindholm B; Stenvinkel P
Am J Kidney Dis; 2006 Nov; 48(5):761-71. PubMed ID: 17059995
[TBL] [Abstract][Full Text] [Related]
9. Impact of Uric Acid Levels on Kidney Disease Progression.
Rincon-Choles H; Jolly SE; Arrigain S; Konig V; Schold JD; Nakhoul G; Navaneethan SD; Nally JV; Rothberg MB
Am J Nephrol; 2017; 46(4):315-322. PubMed ID: 29032376
[TBL] [Abstract][Full Text] [Related]
10. Serum uric acid levels and long-term outcomes in chronic kidney disease.
Miyaoka T; Mochizuki T; Takei T; Tsuchiya K; Nitta K
Heart Vessels; 2014 Jul; 29(4):504-12. PubMed ID: 23929090
[TBL] [Abstract][Full Text] [Related]
11. Urate-Lowering Therapy in Moderate to Severe Chronic Kidney Disease.
Levy G; Shi JM; Cheetham TC; Rashid N
Perm J; 2018; 22():17-142. PubMed ID: 30201087
[TBL] [Abstract][Full Text] [Related]
12. Different clinical impact of hyperuricemia according to etiologies of chronic kidney disease: Gonryo Study.
Watanabe K; Nakayama M; Yamamoto T; Yamada G; Sato H; Miyazaki M; Ito S
PLoS One; 2021; 16(3):e0249240. PubMed ID: 33765101
[TBL] [Abstract][Full Text] [Related]
13. Joint association of hyperuricemia and reduced GFR on cardiovascular morbidity: a historical cohort study based on laboratory and claims data from a national insurance provider.
Neri L; Rocca Rey LA; Lentine KL; Hinyard LJ; Pinsky B; Xiao H; Dukes J; Schnitzler MA
Am J Kidney Dis; 2011 Sep; 58(3):398-408. PubMed ID: 21783292
[TBL] [Abstract][Full Text] [Related]
14. Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function.
Zoppini G; Targher G; Chonchol M; Ortalda V; Abaterusso C; Pichiri I; Negri C; Bonora E
Diabetes Care; 2012 Jan; 35(1):99-104. PubMed ID: 22028277
[TBL] [Abstract][Full Text] [Related]
15. Relationship between serum bilirubin levels s and the progression of renal function in patients with chronic kidney disease and hyperuricemia.
Li M; Li X; Liu Y; Liu X; Song Y; Zhao J; Mohan C; Wu T; Peng A; Qin L
Clin Chim Acta; 2018 Nov; 486():156-161. PubMed ID: 30076802
[TBL] [Abstract][Full Text] [Related]
16. The urate-lowering efficacy and safety of febuxostat versus allopurinol in Chinese patients with asymptomatic hyperuricemia and with chronic kidney disease stages 3-5.
Liu X; Wang H; Ma R; Shao L; Zhang W; Jiang W; Luo C; Zhai T; Xu Y
Clin Exp Nephrol; 2019 Mar; 23(3):362-370. PubMed ID: 30291473
[TBL] [Abstract][Full Text] [Related]
17. High uric acid level is a risk factor for progression of IgA nephropathy with chronic kidney disease stage G3a.
Moriyama T; Itabashi M; Takei T; Kataoka H; Sato M; Shimizu A; Iwabuchi Y; Nishida M; Uchida K; Nitta K
J Nephrol; 2015 Aug; 28(4):451-6. PubMed ID: 25355499
[TBL] [Abstract][Full Text] [Related]
18. Sex Difference in the Associations among Hyperuricemia with New-Onset Chronic Kidney Disease in a Large Taiwanese Population Follow-Up Study.
Chen JH; Tsai CC; Liu YH; Wu PY; Huang JC; Chung TL; Su HM; Chen SC
Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145212
[TBL] [Abstract][Full Text] [Related]
19. Hyperuricemia has increased the risk of progression of chronic kidney disease: propensity score matching analysis from the KNOW-CKD study.
Oh TR; Choi HS; Kim CS; Bae EH; Ma SK; Sung SA; Kim YS; Oh KH; Ahn C; Kim SW
Sci Rep; 2019 Apr; 9(1):6681. PubMed ID: 31040373
[TBL] [Abstract][Full Text] [Related]
20. Association of uric acid and left ventricular mass index with renal outcomes in chronic kidney disease.
Chen SC; Chang JM; Yeh SM; Su HM; Chen HC
Am J Hypertens; 2013 Feb; 26(2):243-9. PubMed ID: 23382409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
